51
Views
9
CrossRef citations to date
0
Altmetric
Review

Thymic hormones in cancer diagnostics and treatment

Pages 93-107 | Published online: 23 Feb 2005

Bibliography

  • ANDREASEN E: Function of the thymus. I. Critical remarks on the theory and experiments of Bomskov. Acta Anat. (1947) 2:275–286.
  • MILLER JFAP: Immunological function of the thymus. Lancet (1961) II:748–749.
  • •• The report which started the numerous experimental observations on cellular immune responses.
  • TRAININ N: Thymic hormones and the immune response. Physiol. Rev. (1974) 54:272–315.
  • RASK-NIELSEN R, ANDREASEN E: Growth of normal thymictissue. Acta Pathol. Microbiol. Scand. (1955)36:1–9.
  • KENDALL MD: Avian thymus glands: a review. Dev. Comp. Immunol. (1980) 4:191–209.
  • RITTER MA, ROZING J, SCHUURMAN HJ: The true function of the thymus? Immunol. Today (1988) 9:189–193.
  • KENDALL MD: Functional anatomy of the thymic microenvironment. J. Anat. (1991) 177:1–29.
  • IZARD J: Introduction to the thymus. Microsc. Res. Tech. (1997) 38:207–208.
  • SCHUURMAN HJ, KUPER CF, KENDALL MD: Thymic microenvironment at the light microscopic level. Microsc. Res. Tech. (1997) 38:216–226.
  • BEARD J: The development and probable function of the thymus. Anat. Anz. (1894) 9:476–486.
  • • Early report on thymic histogenesis.
  • BEARD J: The source of leukocytes and the true function of the thymus. Anat. Anz. (1900) 18:550–573.
  • BEARD J: The origin and histogenesis of the thymus in Raja batis. Zool Jahrbücher, Abt Ontogenie Tiere (1902) 17:403–480.
  • •• The first significant article describing the thymic ontogenesis.
  • PRYMAK T: Beiträge zur Kenntniss des feinern Baues und der Involution der Thymusdrüse bei den Teleostieren. Anat. Anz. (1902) 21:164–177.
  • HAMMARJA: Der gegenwärtige Stand der Morphologie und Physiologie der Thymusdrüse. Wien. Med. Wochenschr. (1909) 2:2746–2750;2795-2801;2910-2916.
  • •• Review of the thymic histogenesis and function at the beginning of last century.
  • HAMMAR JA: Methode, die Menge der Rinde und des Marks der Thymus, sowie die Anzahl und die Größe der Hassallschen Körper zahlenmäßig festzustellen. Z AngewAnat. (1914) 1:311–396.
  • HAMMAR JA: Zur Frage der Histogenese der Thymus¬drüse. Ztrblt AllgPathol. (1923) 33:505–513.
  • HAMMAR JA: Die Menschenthymus in Gesundheit und Krankheit. Teil II. Das Organ unter anormalen Körper-verhältnissen. Zugleich Grundlagen der Theorie der Thymusfunktion. Zeitschr Mikrosk-anat Forsch Erg.-Bd 16 (1929).
  • • • Pathomorphology of the thymus in different diseases.
  • MAXIMOW AA: Untersuchungen über Blut und Bindegewebe. II. Über die Histogenese der Thymus bei Saugetieren. Arch. Mikrosk Anat. (1909) 74:525–621.
  • MAXIMOW AA: Untersuchungen über Blut und Bindegewebe. IV. Über die Histogenese der Thymus bei Amphibien. Arch. Mikrosk Anat. (1912) 79:560–611.
  • MAXIMOW AA: Untersuchungen über Blut und Bindegewebe. V. Über die embryonale Entwicklung der Thymus bei Selachiern. Arch. Mikrosk Anat. (1912) 80:39–88.
  • • One of the earliest articles on the immigration of thymic lymphopoietic stem cells.
  • MAXIMOW AA: Development of non-granular leucocytes (lymphocytes and monocytes) into polyblasts (macrophages) and fibroblasts in vitro. Proc. Soc. Exp. Biol. (1927) 24:570–572.
  • DUSTIN A-P: Contribution à l’ étude du thymus des reptiles. CRAss. Anat. (1909) 11:66–71.
  • DUSTIN A-P: Recherches d’ histologie normale et expérimentale sur le thymus des Amphibiens anoures. P.1. Structure normale, variations saison-nières, variations expérimentales. Arch. Biol. (1913) 28:1–110.
  • DUSTIN A-P: Recherches d’ histologie normale et expérimentale sur le thymus des Amphibiens anoures. Arch. Biol. (1920) 30:601–690.
  • DUSTIN A-P: Apropos d’ une nouvelle explicative de l’ histogênese du thymus. Arch. Biol. (1934) 45:339–352.
  • BODEY B: Histochemistry and histogenesis of the thymus in men during the prenatal development. D Sc. Thesis, Inst. Morphol, Bulgarian Academy of Sciences, Sofia (1977):1–360.
  • NORRIS EH: The morphogenesis and histogenesis of the thymus gland in man: in which the origin of the Hassall’s corpuscles of the human thymus is discov¬ered. Publ Carnegie Inst. Washington (1938), Contrib. to Embryology (No 166)27: 193–207.
  • DISSE J: Das reticuläre Bindegewebe. Ergebn Anat. Entw. (1897) 7:7–28.
  • METCALF D, ISHIDATE M: Periodic acid-Schiff positive giant cells in the mouse thymus cortex. Nature (1961) 191:305.
  • •• The first report of cortically located thymic nurse cells.
  • CHAPMAN WL Jr., ALLEN JR: The fine structure of the thymus of the fetal and neonatal Monkey (Macaca mulatta). Z. Zellforsch (1971) 114:220–233.
  • BODEY B, HADJIOLOFF AI: Histogenesis and prenatal organization of the thymic development in humans. Priroda (1977) 26:22–31.
  • BODEY B, HADJIOLOFF A.I: Thymus development, structure and function. Priroda (1977) 26:11–19.
  • GAUDECKER B VON, MULLER-HERMELINK HK: Ontoge¬netic differentiation of epithelial and non-epithelial cells in the human thymus. Adv. Exp. Med. Biol. (1979) 114:19–23.
  • •• Review on the histogenesis of the complex thymic cellular microenvironment.
  • GAUDECKER B VON, MULLER-HERMELINK HK: Ontogeny and organization of the stationary non-lymphoid cells in the human thymus. Cell Tissue Res. (1980) 207:287–306.
  • SAVINO W, SANTA-ROSA GL: The thymus gland in the loricariidean catfish Harttia sp. Dev. Comp. Immunol. (1982) 6:375–380.
  • SAVINO W: The elastic system in the thymus of the opossum Didelphis marsupialis aurita. Anat. Anz. (1982) 151:70–73.
  • AUERBACH R: Morphogenetic interactions in the development of the mouse thymus gland. Dev Biol. (1960) 2:271–284.
  • •• Controversial article about tissue relationships during organ histogenesis.
  • AUERBACH R: Experimental analysis of the origin of cell types in the development of the mouse thymus. Dev. Biol. (1961) 3:336–354.
  • BODEY B, CALVO W, PRUMMER O, FLIEDNER TM, BORYSENKO M: Development and histogenesis of the thymus in dog. A light and electronmicroscopical study. Dev. Comp. Immunol. (1987) 11:227–238.
  • •• Intimate steps of mammalian thymic histogenesis.
  • KENDALL MD: The morphology of perivascular spaces in the thymus. Thymus (1989) 13:157–164.
  • GAUDECKER B VON: Functional histology of the human thymus. Anat. Embryol. (1991) 183:1–15.
  • BODEY B: Development of lymphopoiesis as a function of the thymic microenvironment. Use of CD8+ cytotoxic T lymphocytes for cellular immuno-therapy of human cancer. In Vivo (1994) 8:915–943.
  • •• Significant work about the complex process of intrathymic T-lymphocyte maturation.
  • BODEY B, BODEY B Jr, KAISER HE: Cell culture observa¬tions of Postnatal Thymic Epithelium: An In vitro Model for Growth and Humoral Influence on Intrathymic T Lymphocyte Maturation. In Vivo (1996) 10:515–526.
  • BODEY B, BODEY B Jr, KAISER HE: Apoptosis in the mammalian thymus during its normal histogenesis and under various in vitro and in vivo experimental conditions. In Vivo (1998) 12:123–134.
  • LE DOUARIN NM, JOTEREAU FV: Tracing of cells of the avian thymus through embryonic life in interspecific chimeras. J. Exp. Med. (1975) 142:17–40.
  • •• Exact experimental demonstration of the immigration of mesenchymal elements into the thymus.
  • LE LIEVRE CS, LE DOUARIN NM: Mesenchymal deriva¬ tives of the neural crest: Analysis of chimeric quail and chick embryos. J. Embryol. Exp. Morphol. (1975) 34:125–154.
  • •• Experimental demonstration of the neural crest related mesenchymal derivatives.
  • LE DOUARIN NM: The neural crest. Cambridge Univ. Press, London, UK (1982):1–259.
  • BODEY B, BODEY B Jr, KEMSHEAD JT, SIEGEL SE, KAISER HE: Identification of neural crest derived cells within the cellular microenvironment of the human thymus employing a library of monoclonal antibodies raised against neuronal tissues. In Vivo (1996) 10:39–47.
  • •• First report on immunocytological detection of neural crest related cells in the thymic stromal cellular microenvironment.
  • KRUISBEEK AM: Thymic factors and T cell maturation in vitro: a comparison of the effects of thymic epithe¬ lial cultures with thymic extracts and thymus dependent serum factors. Thymus (1979) 1:163–185.
  • SINGER KH, HAYNES BF: Epithelial-thymocyte interac¬tions in human thymus. Hum. Immunol. (1987) 20:127–144.
  • KURTZBERG J, DENNING SM, NYCUM LM, SINGER KH, HAYNES BF: Immature human thymocytes can be driven to differentiate into nonlymphoid lineages by cytokines from thymic epithelial cells. Proc. Natl. Acad. Sci. USA (1989) 86:7575–7579.
  • ZUNIGA-PFLUCKER JC, JONES LA, LONGO DL, KRUISBEEK AM: Both TCR/MHC and accessory molecule/MHC interactions are required for positive and negative selection of mature Tcells in the thymus. Cold Spring Harb. Symp. Quant. Biol. (1989) 1 (54 Pt):153–158.
  • RITTER MA, BOYD RL: Development in the thymus: it takes two to tango. Immunol. Today (1993) 14:462–469.
  • MARTIN-FONTECHA A, SCHUURMAN HJ, ZAPATA A: Role of thymic stromal cells in thymocyte education: a comparative analysis of different models. Thymus (1994) 22:201–213.
  • DEFRESNE MP, NABARRA B, VAN VLIET E, WILLEMSEN R, VAN DONGEN H, VAN EWIJK W: The ER-TR4 monoclonal antibody recognizes murine thymic epithelial cells (type 1) and inhibits their capacity to interact with immature thymocytes: immuno-electron microscopic and functional studies. Histochemistry (1994) 101:355–363.
  • DESCHAUX P, KHAN NA: Immunophysiology: the immune system as a multifunctional physiological unit. Cell Mol. Biol. Res. (1995) 41:1–10.
  • ANDERSON G, ANDERSON KL, TCHILIAN EZ, OWEN JJ, JENKINSON EJ: Fibroblast dependency during early thymocyte development maps to the CD25+ CD44+ stage and involves interactions with fibroblast matrix molecules. Eur. J. Immunol. (1997) 27:1200–1206.
  • DE MELLO-COELHO V, VILLA-VERDE DM, DARDENNE M, SAVINO W: Pituitary hormones modulate cell-cell interactions between thymocytes and thymic epithe¬lial cells. J. Neuroimmunol. (1997) 76:39-49. Pituitary hormone action on the direct thymocyte-RE cell teaching’ interactions.
  • MIHOVILOVIC M, DENNING S, MAI Y, WHICHARD LP, PATELDD, ROSES AD: Thymocytes and cultured thymic epithelial cells express transcripts encoding alpha-3, alpha-5 and beta-4 subunits of neuronal nicotinic acetylcholine receptors: preferential transcription of the alpha-3 and beta-4 genes by immature CD4 +8 + thymocytes. J. Neuroimmunol. (1997) 79:176–184.
  • MIHOVILOVIC M, DENNING S, MAI Y et al: Thymocytes and cultured thymic epithelial cells express transcripts encoding alpha-3, alpha-5 and beta-4 subunits of neuronal nicotinic acetylcholine receptors. Preferential transcription of the alpha-3 and beta-4 genes by immature CD4+8+ thymocytes and evidence for response to nicotine in thymocytes. Ann. NY Acad. Sci. (1998) 841:388–392.
  • MIRALLES GD, SMITH CA, WHICHARD LP, MORSE MA, HAYNES BF, PATEL DD: CD34+CD38-lin- cord blood cells develop into dendritic cells in human thymic stromal monolayers and thymic nodules. J. Immunol. (1998) 160:3290–3298.
  • JOLLY J: Sur les organes lympho-épithéliaux. C R Soc. Biol. (1913) 74:540–543.
  • JOLLY J: Le tissue lymphoïde, considéré comme un tissu de resérve. Arch. Anat. Micr. (1920) 83:1209–1212.
  • JOLLY J: Le thymus et les organes lymphoïdes. C R Ass Anat. (1924) 19:1–10.
  • •• The thymus reported as central organ of lymphopoiesis.
  • JOLLY J: Le thymus est-il un organe lymphoïde. Bull d’Histol. (1924) 1:176–179.
  • JOLLY J and LIEURE C: Recherches sur la greffe du thymus. Phénomènes histologiques de la reconstitu¬tion du thymus greffé. Arch. Anat. Micr. (1932) 28:159–221.
  • JOLLY J, TANNENBERG C: Sur l’ existence de centres germinatifs dans le substance médullaire d’un thymus de chat. C R Soc. Biol. (1924) 90:405–407.
  • JOLLY J, TANNENBERG C: Centres germinatifs dans le thymus. Arch. Anat. Micr. (1931) 27:127–147.
  • GRÉGOIRE C: Recherches sur le symbiose lymphoépithéliale au niveau du thymus de Mammifere. Arch. Biol. (1935) 46:717–820.
  • GRÉGOIRE C, DUCHATEAU G: A study on lympho- epithelial symbiosis in thymus. Reactions of the lymphatic tissue to extracts and to implants of epithe¬lial components of thymus. Arch. Biol. (1956) 68:269–296.
  • •• One of the earliest articles about the detailed steps of intrathymic lymphopoiesis monitored by the RE cells.
  • SAVINO W, CIRNE-LIMA EO, SOARES JF, LEITE-DE- MORAES M DO C, ONO IP, DARDENNE M: Hydrocorti¬sone increases the numbers of KL1+cells, a discrete thymic epithelial cell subset characterized by high molecular weight cytokeratin expression. Endocri¬nology (1988) 123:2557–2564.
  • GOYA RG, SOSA YE, QUIGLEY KL, REICHHART R, MEITES J: Homeostatic thymus hormone stimulates corticos¬terone secretion in a dose-and age-dependent manner in rats. Neuroendocrinology (1990) 51:59–63.
  • TIMSIT J, SAVINO W, SAFIEH B, CHANSON P, GAGNERAULT MC, BACH J-F, DARDENNE M: Growth hormone and insulin-like growth factor-I stimulate hormonal function and proliferation of thymic epithelial cells. J. Clin. Endocrinol. Metab. (1992) 75:183–188.
  • • Hormone and growth factor functional effect on thymic RE cells.
  • WICK G, HU Y, SCHWARZ S, KROEMER G: Immunoendo- crine communication viathe hypothalamo-pituitary-adrenal axis in autoimmune diseases. Endocr. Rev. (1993) 14:539–563.
  • GEENEN V, ROBERT F, DEFRESNE MP, BONIVER J, LEGROS JJ, FRANCHIMONT P: Neuroendocrinology of the thymus. Horm. Res. (1989) 31:81–84.
  • DARDENNE M, SAVINO W: Control of thymus physiology by peptidic hormones and neuropeptides. Immunol. Today (1994) 15:518–523.
  • SAVINO W, DARDENNE M: Immune-neuroendocrine interactions. Immunol. Today (1995) 16:318–322.
  • • Report on the complex neuroendocrine regulation of the immune responses.
  • DEMAN J, VAN MEURS M, CLAASSEN E, HUMBLET C, BONIVIER J, DEFRESNE MP: In vivo expression of interleukin-1 beta (IL-1 beta), IL-2, IL-4, IL-6, tumour necrosis factor-alpha and interferon-gamma in the fetal murine thymus. Immunology (1996) 89:152–157.
  • EWIJK VAN W, DE KRUIF J, GERMERAAD WT et al.: Subtractive isolation of phage-displayed single-chain antibodies to thymic stromal cells by using intact thymic fragments. Proc. Natl. Acad. Sci. USA (1997) 94:3903–3908.
  • VANNESTE Y, THOME AN, VANDERSMISSEN E et al.: Identification of neurotensin-related peptides in human thymic epithelial cell membranes and relationship with major histocompatibility complex class I molecules. J. Neuroimmunol. (1997) 76:161–166.
  • • Cellular localisation of neuroendocrine peptides in the cells of thymic RE meshwork.
  • SAVINO W, VILLA-VERDE DM, ALVES LA, DARDENNE M: Neuroendocrine control of the thymus. Ann. NY Acad. Sci. (1998) 840:470–479.
  • •• Significant attempt to overview the neuroendocrine regula- tion on the cellular immunity.
  • GEENEN V, MARTENS H, VANDERSMISSEN E, ACHOUR I, KECHA O, FRANCHIMONT D: Cellular and molecular aspects of thymic T-cell education in neuroendocrine self principles. Implications for autoimmunity. Ann. NY Acad. Sci. (1998) 840:328–337.
  • MARTENS H, KECHA O, CHARLET-RENARD C, DEFRESNE MP, GEENEN V: Neurohypophysial peptides stimulate the phosphorylation of pre-T cell focal adhesion kinases. Neuroendocrinology (1998) 67:282–289.
  • DE MELLO-COELHO V, GAGNERAULT MC, SOUBER- BIELLE JC et al: Growth hormone and its receptor are expressed in human thymic cells. Endocrinology (1998) 139:3837–3842.
  • BODEY B, BODEY B, JR., SIEGEL SE, KAISER HE: Involu¬ tion of the mammalian thymus, one of the leading regulators of aging. In Vivo (1997) 11:421–440.
  • • Report on a new version of the immunological hypothesis of ageing.
  • DARDENNE M, PAPIERNIK M, BACH JF, STUTMAN O: Studies on thymus products. 3. Epithelial origin of the serum thymic factor. Immunology (1974) 27:299–304.
  • BODEY B, BODEY B, JR., SIEGEL SE, KAISER HE: The role of zinc in pre- and postnatal mammalian thymic immunohistogenesis. In Vivo (1998) 12:695–722.
  • •• Detailed report on the influence of one microelement on thymic immunophysiology.
  • SEIKI K, SAKABE K: Sex hormones and the thymus in relation to thymocyte proliferation and maturation. Arch. Histol. Cytol. (1997) 60:29–38.
  • MARSHALL GD, JR., LOW TL, THURMAN GB et al: Overview of thymosin activity. Cancer Treat. Rep. (1978) 62:1731–1737.
  • • Report on the THN effects.
  • MARSHALL GD Jr., THURMAN GB, LOW TL, GOLDSTEIN AL: Thymosin: basic properties and clinical applica¬tion in the treatment of immunodeficiency diseases and cancer. Recent Results Cancer Res. (1980) 75:100–105.
  • LOW TL, THURMAN GB, CHINCARINI C et al.: Current status of thymosin research: evidence for the existence of a family of thymic factors that control T-cell maturation. Ann. NY Acad. Sci. (1979) 332:33–48.
  • AHMED A, WONG DM, THURMAN GB et al.: T-lymphocyte maturation: cell surface markers and immune function induced by T-lymphocyte cell-free products and thymosin polypeptides. Ann. NY Acad. Sci. (1979) 332:81–94.
  • LAURITZSEN GF, HOFGAARD PO, SCHENCK K, BOGEN B: Clonal deletion of thymocytes as a tumor escape mechanism. Int.J. Cancer (1998) 78:216–222.
  • DOMINGUEZ F, MAGDALENA C, CANCIO E etal: Tissue concentrations of prothymosin alpha: a novel prolif¬eration index of primary breast cancer. Eur. J. Cancer (1993) 29A:893–897.
  • LOIDI L, VIDAL A, ZALVIDE JB, PUENTE JL, REYES F, DOMINGUEZ F: Development of ELISA to estimate thymosin alpha 1, the N terminus of prothymosin alpha, in human tumors. Clin. Chem. (1997) 43:59–63.
  • WU CG, BOERS W, REITSMA PR, VAN DEVENTER SJ, CHAMULEAU RA: Overexpression of prothymosin alpha, concomitant with c-myc, during rat hepatic carcinogenesis. Biochem. Biophys. Res. Commun. (1997) 232:817–821.
  • FRAGA M, GARCIA-CABALLERO T, DOMINGUEZ F, PEREZ-BECERRA E, BEIRAS A, FORTEZAJ: Immunohisto- chemical location of prothymosin alpha in regener¬ating human hepatocytes and hepatocellular carcinomas. Virchows Arch. A Pathol. Anat. Histopathol (1993) 423:449–452.
  • WU CG, HABIB NA, MITRY RR, REITSMA PH, VAN DEVENTER SJ, CHAMULEAU RA: Overexpression of hepatic prothymosin alpha, a novel marker for human hepatocellular carcinoma. Br. J. Cancer (1997) 76:1199–1204.
  • •• Thymic proTHN considered as new immunocytological marker of hepatocellular cancer cells.
  • MAGDALENA C, DOMINGUEZ F, LOIDI L, PUENTE JL: Tumour prothymosin alpha content, a potential prognostic marker for primary breast cancer. Br. J. Cancer (2000) 82 (3):584–590.
  • CALIFANO D, MONACO C, SANTELLI G etal.: Thymosin beta-10 gene overexpression correlated with the highly malignant neoplastic phenotype of transformed thyroid cells in vivo and in vitro. Cancer Res. (1998) 58:823–828.
  • VERGHESE-NIKOLAKAKI S, APOSTOLIKAS N, LIVANIOU E, ITHAKISSIOS DS, EVANGELATOS GP: Preliminary findings on the expression of thymosin beta-10 in human breast cancer. Br J. Cancer (1996) 74:1441–1444.
  • GOLD JS, BAO L, GHOUSSOUB RA, ZETTER BR, RIMM DL: Localization and quantitation of expression of the cell motility-related protein thymosin beta15 in human breast tissue. Mod. Pathol. (1997) 10:1106–1112.
  • BAO L, LODA M, ZETTER BR: Thymosin beta15 expres¬sion in tumor cell lines with varying metastatic potential. Clin. Exp. Metastasis (1998) 16:227–233.
  • CHAKRAVATRI A, ZEHR EM, ZIETMAN AL et al.: Thymosin beta-15 predicts for distant failure in patients with clinically localized prostate cancer-results from a pilot study. Urology (2000) 55(5):635–638.
  • KATER L, OOSTEROM R, McCLURE J, GOLDSTEIN AL: Presence of thymosin-like factors in human thymic epithelium conditioned medium. Int. J. Immunophar-macol. (1979) 1:273–284.
  • BERNARDI G, COMSA J: Chromatographic purification of a thymus preparation endowed with hormonal activity. Experientia (1965) 21:416–417.
  • •• First report of the isolation of the thymic homeopathic hormone (THH).
  • COMSA J: Thymus hormones. Facts and problems. Med. Welt (1980) 31:533–536.
  • COMSA J, LEONHARDT H, WEKERLE H: Hormonal coordination of the immune response. Rev. Physiol Biochem. Pharmacol. (1982) 92:115–191.
  • SCHULOF RS, LLOYD MJ, CLEARY PA etal: Arandomized trial to evaluate the immunorestorative properties of synthetic thymosin-alpha 1 in patients with lung cancer. J. Biol. Response Mod. (1985) 4:147–158.
  • •• First report on the possibility to restore the human immune responses in cancer patients.
  • SCHULOF RS: Thymic peptide hormones: basic proper¬ ties and clinical applications in cancer. Crit. Rev. Oncol Hematol. (1985) 3:309–376.
  • •• A great review article about the structure and therapeutical significance of thymic peptides.
  • LOW TL, GOLDSTEIN AL: Thymic hormones: an overview. MethodsEnzymol. (1985) 116:213–219.
  • •• Short review of thymic peptides.
  • LOW TL, GOLDSTEIN AL: Thymosin beta 4. Methods Enzymol. (1985) 116:248–255.
  • LOW TL, GOLDSTEIN AL: Thymosin alpha 1 and polypeptide beta 1. Methods Enzymol. (1985) 116:233–248.
  • LOW TL, GOLDSTEIN AL: Thymosin fraction 5 and 5A. Methods Enzymol. (1985) 116:219–233.
  • HADDENJW: Thymic endocrinology. Ann. NY Acad. Sci. (1998) 840:352–358.
  • FAVALLI C, MASTINO A, JEZZI T, GRELLI S, GOLDSTEIN AL, GARACI E: Synergistic effect of thymosin alpha-1 and alpha-beta interferon on NK activity in tumor-bearing mice. Int. J. Immunopharmacol. (1989) 11:443–450.
  • GARACI E, PICA F, MASTINO A, PALAMARA AT, BELARDELLI F, FAVALLIC: Antitumor effectofthymosin alpha 1/interleukin-2 or thymosin alpha 1/interferon alpha, beta following cyclophosphamide in mice injected with highly metastatic Friend erythroleu-kemia cells. J. Immunother. (1993) 13(1):7–17.
  • MASTINO A, FAVALLI C, GRELLI S, INNOCENTI F, GARACI E: Thymosin alpha1potentiates interleukin 2-induced cytotoxic activity in mice. Cell Immunol. (1991) 133:196–205.
  • MASTINO A, FAVALLI C, GRELLI S, RASI G, PICA F, GOLDSTEIN AL, GARACI E: Combination therapy with thymosin alpha1potentiates the anti-tumoractivity of interleukin-2 with cyclophosphamide in the treatment of the Lewis lung carcinoma in mice. Int. J. Cancer (1992) 50:493–499.
  • PICA F, FRASCHETTI M, MATTEUCCI C, TUTHILL C, RASI G: High doses of thymosin alpha 1 enhance the anti-tumor efficacy of combination chemo-immunotherapy for murine B16 melanoma. AntiCancer Res. (1998) 18:3571–3578.
  • OPHIR R, PECHT M, KEISARI Y et al.: Thymic humoral factor-gamma 2 (THF-gamma 2) immunotherapy reduces the metastatic load and restores immunocom-petence in 3LL tumor-bearing mice receiving anticancer chemotherapy. Immunopharmacol. Immunotoxicol. (1996) 18:209–236.
  • LOPEZ M, CARPANO S, CAVALIERE R et al.: Biochemo-therapy with thymosin alpha 1, interleukin-2 and dacarbazine in patients with metastatic melanoma: clinical and immunological effects. Ann. Oncol. (1994) 5:741–746.
  • SPANGELO BL, FARRIMOND DD, THAPA M et al.: Thymosin fraction 5 inhibits the proliferation of the rat neuroendocrine MMQ pituitary adenoma and C6 glioma cell lines in vitro. Endocrinology (1998) 139:2155–2162.
  • LOPEZ M, DI LAURO L, PAOLETTI G et al.: Sequential biochemotherapy for metastatic colorectal cancer using fluorouracil, folinic acid, thymopentin and interleukin-2: clinical and immunological effects. Ann. Oncol. (1995) 6:1011–1017.
  • HEIDECKE H, ECKERT K, SCHULZE-FORSTER K, MAURER HR: Prothymosin alpha 1 effects in vitro on chemotaxis, cytotoxicity and oxidative response of neutrophils from melanoma, colorectal and breast tumor patients. Int. J. Immunopharmacol. (1997) 19:413–420.
  • MOODY TW, LEYTON J, ZIA F, TUTHILL C, BADAMCHIAN M, GOLDSTEIN AL: Thymosin-alpha 1 is chemopreven-tive for lung adenoma formation in A/J mice. Cancer Lett. (2000) 155(2):121–127.
  • CASCINELLI N, BELLI F, MASCHERONI L, LENISA L, CLEMENTE C: Evaluation of clinical efficacy and tolerability of intravenous high dose thymopentin in advanced melanoma patients. Melanoma Res. (1998) 8:83–89.
  • SALVATI F, RASI G, PORTALONE L, ANTILLI A, GARACI E: Combined treatment with thymosin-alpha1 and low-dose interferon-alpha after ifosfamide in non-small cell lung cancer: a phase-II controlled trial. AntiCancer Res. (1996) 16:1001–1004.
  • PILARSKI LM, GILLITZER R, ZOLA H, SHORTMAN K, SCOLLAYR: Definitionofthe thymic generative lineage by selective expression of high molecular weight isoforms of CD45 (T200). Eur. J. Immunol. (1989) 19:589–597.
  • FUJII Y, OKUMURAM, INADA K, NAKAHARA K, MATSUDA H: CD45 isoform expression during T cell develop¬ment in the thymus. Eur. J. Immunol. (1992) 22:1843–1850.
  • ERKELLER-YUKSEL FM, DENEYS V, YUKSEL B et al.: Age-related changes in human blood lymphocyte subpopulations. J. Pediatr. (1992) 120:216–222.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.